Semma Therapeutics

📍 Cambridge, United States🗓 Founded 2015👥 87 employees💰 Last funded Dec 2017
Biotechnology🌐 semma-tx.com
Website LinkedIn
Semma Therapeutics is pioneering the new treatment paradigm of using cells as medicine. Semma’s new class of regenerative medicine therapies couples its breakthrough stem cell technologies with proprietary delivery systems designed to protect cells from the immune system. Ongoing research at Semma Therapeutics is focused on combining these highly-differentiated active cells with a state-of-the-art device to provide a functional cure for patients with diabetes. Semma Therapeutics is working to bring new therapeutic options to the clinic and improve the lives of patients. The company is headquartered in Cambridge, MA, with operations in Providence, RI. For more information, visit www.semma-tx.com.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Semma Therapeutics?
Semma Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Semma Therapeutics last raise funding?
The most recent investment in Semma Therapeutics recorded on gritt.io was in December 2017.
When was Semma Therapeutics founded?
Semma Therapeutics was founded in 2015.
What industry is Semma Therapeutics in?
Semma Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Semma Therapeutics based?
Semma Therapeutics is headquartered in Cambridge, United States.